Breaking News
January 19, 2019 - Newly identified subset of immune cells may be key to fighting chronic inflammation
January 19, 2019 - New immune response regulators discovered
January 18, 2019 - Poor blood oxygenation during sleep predicts chance of heart-related death
January 18, 2019 - First international consensus on the diagnosis and management of fibromuscular dysplasia
January 18, 2019 - Rapid resistance gene sequencing technology can hasten identification of antibiotic-resistant bacteria
January 18, 2019 - Researchers develop artificial enzymatic pathway for synthesizing isoprenoids in E. coli
January 18, 2019 - Scientists advise caution in immunotherapy research
January 18, 2019 - How children across the world develop language
January 18, 2019 - Columbia Medical Student Receives McDonogh Scholarship
January 18, 2019 - Secretive ‘Rebate Trap’ Keeps Generic Drugs For Diabetes And Other Ills Out Of Reach
January 18, 2019 - Plant based diet could be the best option for the planet says commission
January 18, 2019 - New conservation practice could reduce nitrogen from agricultural drainage, study shows
January 18, 2019 - UIC researchers receive $1.7 million NCI grant to study Southeast Asian fruit
January 18, 2019 - New study determines the fate of DNA derived from genetically modified food
January 18, 2019 - Scientists develop new gene therapy that prevents axon destruction in mice
January 18, 2019 - Study finds critically low HPV vaccination rates among younger adolescents in the U.S.
January 18, 2019 - Brain cells involved in memory play key role in reducing future eating behavior
January 18, 2019 - Risk for Conversion of MS Varies With Different Therapies
January 18, 2019 - Investigational cream may help patients with inflammatory skin disease
January 18, 2019 - Medical school news office receives six writing awards | News Center
January 18, 2019 - County By County, Researchers Link Opioid Deaths To Drugmakers’ Marketing
January 18, 2019 - Research reveals risk for developing more than one mental health disorder
January 18, 2019 - Scientists discover a dramatic pattern of bone growth in female mice
January 18, 2019 - Study finds link between lengthy periods of undisturbed maternal sleep and stillbirths
January 18, 2019 - New nuclear medicine method could improve detection of primary and metastatic melanoma
January 18, 2019 - Combination therapy shows high efficacy in treating people with leishmaniasis and HIV
January 18, 2019 - Health Tip: Don’t Ignore Changes in Skin Color
January 18, 2019 - Dietary Recommendations for Healthy Children
January 18, 2019 - Eliminating the latent reservoir of HIV
January 18, 2019 - Pain From The Government Shutdown Spreads. This Time It’s Food Stamps
January 18, 2019 - Newly discovered regulatory mechanism helps control fat metabolism
January 18, 2019 - New rapid blood tests could speed up TB diagnosis, save the NHS money
January 18, 2019 - Researchers develop intelligent system for ‘tuning’ powered prosthetic knees
January 18, 2019 - Monoclonal antibody pembrolizumab prolongs survival in patients with squamous cell carcinoma
January 18, 2019 - New research detects mosquito known to transmit malaria for the first time in Ethiopia
January 18, 2019 - Lumex Instruments’ RA-915AM monitor installed at Hg treatment plant in Almadén, Spain
January 18, 2019 - ACCC survey finds multiple threats to growth of cancer programs
January 18, 2019 - Meeting the challenge of engaging men in HIV prevention and treatment
January 18, 2019 - Furloughed Feds’ Health Coverage Intact, But Shutdown Still Complicates Things
January 18, 2019 - Experts discuss various aspects on health risks posed by fumigated containers
January 18, 2019 - Researchers use gene-editing tool CRISPR/Cas9 to limit impact of parasitic diseases
January 18, 2019 - Alpha neurofeedback training could be a means of enhancing learning success
January 18, 2019 - Innovative ‘light’ method demonstrates positive results in fight against malignant tumors
January 18, 2019 - The cytoskeleton of neurons found to play role in Alzheimer’s disease
January 18, 2019 - New resource-based approach to improve HIV care in low- and middle-income countries
January 18, 2019 - Bedfont appoints Dr Jafar Jafari as first member of the Gastrolyzer Medical Advisory Board
January 18, 2019 - New study shows link between secondhand smoke and cardiac arrhythmia
January 18, 2019 - DZIF scientists reveal problems with available diagnostics for Zika and chikungunya virus
January 18, 2019 - Breast cancers more likely to metastasize in young women within 10 years of giving birth
January 18, 2019 - Over 5.6 million Americans exposed to high nitrate levels in drinking water
January 18, 2019 - Blood vessels can now be created perfectly in a petri dish
January 18, 2019 - Study identifies prominent socioeconomic and racial disparities in health behavior in Indiana
January 18, 2019 - Young-Onset Type 2 Diabetes Tied to Increased Hospitalization Risk
January 18, 2019 - For-profit nursing schools associated with lower performance on nurse licensure test
January 18, 2019 - Considering the culture of consent in medicine
January 18, 2019 - Researchers identify comprehensive guidelines for managing severe atopic dermatitis
January 18, 2019 - Analyzing proteins in blister fluid may classify burn severity more accurately
January 18, 2019 - Study finds higher suicide rates among youth who were Medicaid enrollees
January 18, 2019 - Opioid drugs often overprescribed to children for pain relief, say CHOP surgeons
January 18, 2019 - New biodegradable wound dressing material accelerates healing
January 18, 2019 - Life in Space May Take Toll on Spinal Muscles
January 18, 2019 - Bulldogs’ screw tails linked to human genetic disease
January 18, 2019 - Immunotherapy target identified for pediatric cancers
January 18, 2019 - Financial stress may increase heart disease risk in African Americans
January 18, 2019 - Scientists solve another piece of Ebola virus puzzle
January 18, 2019 - New project finds how endocrine disruptors interfere with thyroid functions
January 18, 2019 - Research finds decline in ketone body utilization when coronary circulation is reduced
January 18, 2019 - Let’s map our DNA and save billions each year in health costs
January 18, 2019 - AI demonstrates potential to identify irregular heart rhythms as well as humans
January 17, 2019 - Study shows link between air pollution and increased risk of sleep apnea
January 17, 2019 - Neck-strengthening exercises can protect athletes from concussions
January 17, 2019 - Computer model shows how to better control MRSA outbreaks
January 17, 2019 - Pain is unpleasant, and now scientists have identified the set of responsible neurons
January 17, 2019 - CUIMC Celebrates 2018-2019
January 17, 2019 - Study reveals potential pathway for endothelial cells to avoid apoptosis
January 17, 2019 - Hamilton Storage launches LabElite DeCapper SL to expand LabElite product family
January 17, 2019 - Location of epigenetic changes co-locate with genetic signal causing psychartric disorder
January 17, 2019 - Researchers awarded 6.1 million euros to address female fertility problems
January 17, 2019 - Counseling appointments fail to reduce weight gain during pregnancy, shows study
January 17, 2019 - Contraceptive patch that could provide 6 months of contraception within seconds
Researcher uses smartphone to detect breast cancer gene

Researcher uses smartphone to detect breast cancer gene

image_pdfDownload PDFimage_print
Credit: CC0 Public Domain

With increasing demand and pressure on healthcare budgets, progressive initiatives are being taken to make healthcare more patient-centered, reliable, accessible and affordable. Point-of-care devices have become a cost-efficient and feasible way for people to monitor their own health, as opposed to waiting weeks for expensive test results.

Seeing the many POC devices that already exist for diabetes, pregnancy and other health conditions, LSU Mechanical Engineering Assistant Professor Manas Gartia wondered why there couldn’t be one for breast cancer genetic testing.

“Breast cancer is the second most common cancer in women in the United States,” Gartia said. “In 2015, 41,523 women died of breast cancer in the U.S., with 3,523 of those in Louisiana. We believe that early detection saves lives. That’s why genetic testing is so popular. People want to catch it [cancer] before it’s found in a mammogram.”

Gartia and his team of researchers have created an accessible way for women – and men – to test for the “BReast CAncer gene one,” more commonly known as BRCA1. If the test comes back positive, it means there is a mutation in the BRCA1 gene and, therefore, a much higher risk of developing breast or ovarian cancer in women and pancreatic cancer in men.

According to the Maurer Foundation, approximately 60 percent of women who inherit the harmful gene mutation will develop breast cancer. However, not all breast cancer is due to this genetic mutation and not all women or men with the mutation will develop breast cancer.

“We chose the BRCA1 gene due to its high prevalence in half of the global population, and secondly, because a lot of researched data about the alterations and mutations are available at the gene level from various databases,” Gartia said.

Rather than pay for a home test kit, which would still require a doctor’s visit for an explanation, or go to the doctor, where the wait time for results could be several weeks and cost thousands of dollars, Gartia proposes doing a DNA microarray analysis using a smartphone and portable fluorescence microarray-based imaging system called the FluoroZen, which provides results in 20 minutes.

“The rapid development of smartphone technology with increasing computing power, high-resolution cameras, GPS capabilities and internet connectivity has enabled a smartphone-based POC testing [POCT] platform suitable for field deployment,” Gartia said.

The FluoroZen works by analyzing DNA – saliva or blood – that is placed on nitrocellulose, or NC, paper, which is then set on a glass slide holder. The FluoroZen detects the fluorescent oligonucleotide spots on the NC paper using two light spectrum filters – one to excite the fluorescent dye and the second to capture the emission spectrum. The spots with higher intensity will be brighter, indicating the presence of the mutated BRCA1 gene. A smartphone, which is attached to the POC device, then shows the results (a simple YES or NO) on the screen after taking a picture of the spots.

“There will be a smartphone app to download so you can see the results,” Gartia said.

Gartia believes that early detection is the best way to beat cancer, which is why he and his team want to make the FluoroZen accessible to everyone through their general physician’s office.

“According to 2015 research data, there are 1.7 million women in 106 low-access counties [LAC] in the U.S. who must travel more than 150 miles to see a gynecologic oncologist,” Gartia said. “In 1,125 LACs, 14.8 million women can’t find one within a 50-mile radius. In Louisiana, there are only eight gynecologic oncologists available to 669,705 women in LACs, which makes up 44 percent of the state.”

On the FluoroZen testing being more affordable, Gartia said it would only cost $50 or less to run a test, though that’s no guarantee doctors and hospitals wouldn’t increase the cost.

“Doctors can charge more, but generally, all the costs are covered by insurance,” he said. “Most of the cost during our research is due to reagents and purification and extraction of DNA from blood or saliva. The cost of the microfluidic device is less than $5 and less than $1 if mass produced.”

Though Gartia prefers to focus on BRCA1 testing for now, he says the FluoroZen can be used for many different things.

“Utilizing paper microfluidics for biological assays, along with the smartphone readout setup opens up the possibility of transferring various clinical, as well as environmental, tests to POCT,” Gartia said. “Dr. Melvin [LSU Chemical Engineering Professor Adam Melvin] is interested in finding neurotoxins and hepatotoxins, such as microcystin and cyanopeptolin, due to harmful golden algal blooms found in Lake Pontchartrain. If we can attach that toxin to a fluorescent dye, then we can detect whether that particular toxin is in your water sample.”

Gartia looks forward to the day his FluoroZen will be completed and available to the public through their doctor’s office. Until then, he emphasizes the importance of early detection and, on an optimistic note, stresses that not all women and men should get tested for the BRCA1 gene.

“Only 10 percent of people have this inherited gene,” he said. “There are many questions to answer before getting tested.”


Explore further:
Genetic predisposition to breast cancer due to non-brca mutations in ashkenazi Jewish women

More information:
To learn more about getting tested for the BRCA1 gene, visit ww5.komen.org/BreastCancer/Gen … pGeneticTesting.html

Provided by:
Louisiana State University

Tagged with:

About author

Related Articles